HealthTech
Oura Raised $900M at an $11B Valuation. Four Days Later, It Got Sued Over the Science Behind the Ring
A proposed class action says Oura's "95% accurate" sleep-stage claim is closer to a coin flip. It lands weeks after the company added Eli Lilly as an investor and took on a $900 million bank facility — the kind of move companies make right before an IPO.